alexa Role of Smad3 and S1P Signaling in Mandibular Condylar Cartilage Homeostasis | OMICS International
ISSN: 2572-4916
Journal of Bone Research
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Role of Smad3 and S1P Signaling in Mandibular Condylar Cartilage Homeostasis

Takashi Izawa*, Islamy Rahma Hutami, Hiroki Mori and Eiji Tanaka

Department of Orthodontics and Dentofacial Orthopedics, Tokushima University, Graduate School of Biomedical Sciences, Japan

*Corresponding Author:
Takashi Izawa
Department of Orthodontics and Dentofacial Orthopedics
Tokushima University, Graduate School of Biomedical Sciences
3-18-15 Kuramoto-cho, Tokushima 7708504, Japan
Tel: +81-88-633-7357
Fax: +81-88-633-9139
E-mail: [email protected]

Received date: July 17, 2017; Accepted date: July 24, 2017; Published date: July 31, 2017

Citation: Izawa T, Hutami IR, Mori H, Tanaka E (2017) Role of Smad3 and S1P Signaling in Mandibular Condylar Cartilage Homeostasis . J Bone Res 5:178. doi:10.4172/2572-4916.1000178

Copyright: © 2017 Izawa T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Bone Research

Abstract

Osteoarthritis (OA), the most common degenerative joint disease, results from an imbalance between chondrocyte-controlled anabolic and catabolic processes. OA is characterized by progressive degradation of components of the Extracellular Matrix (ECM) within the articular cartilage, correlated with secondary inflammation. Several studies had investigated the morphological and biochemical changes during OA progression. However, a comprehensive study of the OA pathogenesis is still remains to be elucidated to find the best therapy for OA. In this review, recent advances in our understanding of the mechanisms of action of Sphingosine 1-phosphate (S1P) and Smad3 independently and in relation to Temporomandibular Joint Osteoarthritis (TMJ-OA) will be discussed. S1P receptors are expressed on the cell surface and are internalized upon binding of the bioactive lipid, S1P, as part of the migratory response. Meanwhile, Smad3 is an intracellular signaling molecule that mediates signaling from transforming growth factor-β (TGF-β) and activin receptors. Crosstalk between the TGF-β/Smad3 and S1P/S1P3 signaling pathways regulates cell motility and apoptosis in chondrocyte cells. Thus, Smad3/S1P3 signaling in chondrocytes may be responsible for the development of TMJ-OA, and the potential for these proteins to represent targets for the treatment of TMJ-OA warrants further study.

Keywords

Smad3; S1P; Chondrocyte; Migration; TMJ-OA

Introduction

Mandible, a part of the human masticatory system, through contractions of the neuromuscular controls direction of joint loads as dictated by dental eruption and growth of the TMJ eminence [1,2]. The motion of the mandible is relative to the cranial base and distributes the normal stresses of function (speaking and chewing) and parafunction (bruxism and clenching) [3]. A number of clinical orofacial conditions that involve the masticatory musculature, the TMJ, and associated structures are referred to as Temporo Mandibular Disorders (TMD). A severe TMD is osteoarthritis (OA) which often affects the TMJ of patients and involves changes in the subchondral bone and progressive cartilage degradation [4].

In the mandibular condyle, endochondral ossification is the primary process by which subchondral bone is formed and this process is regulated by endogenously expressed factors in chondrocyte. Loss of cartilage integrity caused by (bio)mechanical, biochemical, inflammatory, or immunologic in character disturbs the chondrocytecontrolled balance between synthesis and degradation of the ECM components [5,6]. Increased synthesis and activity of proteases, resulting in an initially degradation of articular cartilage [6,7]. During late stage of OA, severe fibrillated and eroded tissue is may appear and neovascularization of TMJ articular cartilage may be present. Denudation of subchondral bone is frequently seen. Synovial membrane may appear hypervascularization and hyperthropic, or fibrotic and disc displacement and perforation may develop [6].

To date, the relationship between subchondral bone abnormalities and the onset of TMJ-OA has not been determined. It is hypothesized that the accumulation of chondroprogenitor cells at injury sites is due to the migration of these cells from the surrounding matrix [8-12]. Migratory chondroprogenitor cells that are present in cartilage represent a valuable resource for improving cell recruitment into cartilage defects without the need for perforation of the subchondral bone plate. In addition, migratory chondroprogenitor cells have the potential to support the endogenous repair of blunt injured cartilage when traumatic chondrocyte loss has occurred. However, the potential physiologic and/or pathologic functions of chondroprogenitor cells and their migratory effects on healing in TMJ-OA joints remain unknown.

Several studies have reported that a subset of the effects elicited by the TGF-β/Smad3 signaling pathway are transmitted via a pathway that is initiated by activation of Sphingosine Kinase (Sphk), followed by intracellular generation of the bioactive lipid, Sphingosine 1- phosphate (S1P) [13]. Here, we highlight that TGF-β/Smad3 signaling influences cartilage homeostasis by influencing S1P/S1P receptor signaling and chondrocyte migration.

Pathogenesis of TMJ-OA

In elderly adults, chronic disability is most often caused by OA. In the early stages of OA, it has recently been demonstrated that low bone mineral density and increased bone turnover are observed in the knee joint [14-16]. Efficacies of bone resorption inhibitors for the rescue of OA have also been reported [15,17,18]. Taken together, these results suggest that abnormal subchondral bone remodeling is important in the pathogenesis of knee OA.

However, the TMJ is one of the most common sites of OA and TMJOA may be part of generalized OA [19-21]. TMJ-OA is present in 70% persons of 73-75-year age group and 89% of patients with or without reduction of disc displacement [20,22]. TMJ-OA can affect all TMJ tissues to induce anatomical changes and severe pain [4].

It is hypothesized that the subchondral bone has an etiological role in TMJ-OA pathology based on recent observations that increased remodeling of mandibular condylar subchondral bone occurs in the early stages of TMJ-OA [23-25]. Moreover, the relationship between the development of TMJ-OA and the abnormalities in subchondral bone remains to be determined, and this is an area of active study.

The key mediators of cartilage degradation in vivo and in vitro include the Matrix Metallo Proteinases (MMPs) and members of the closely related family of a disintegrin and Metallo Proteases (ADAMs) with Thrombospondin motifs (ADAM-TS) [26,27]. Roles for matrix MMP-13 and ADAM-TS5 in this degeneration process have been demonstrated [28-33]. Subsequently, key roles have been identified for complement component 5 (C5) [34] and hypoxia-inducible factor-2α (HIF-2α) [35,36]. As OA progresses, articular chondrocytes express interleukin-1 (IL-1), tumor necrosis factor-α (TNF- α), runt-related transcription factor 2 (RUNX2), alkaline phosphatase, MMP-13, and type X collagen. Concomitantly, articular cartilage exhibits expanded calcified cartilage zones and low levels of proteoglycans [37-42].

Nitric Oxide (NO) as a free radical play a role in the apoptosis of chondrocytes and inhibits proteoglycan synthesis. These may contribute to the abnormal chondral calcification and osteophyte formation [43,44]. Mitogen-inducible gene-6 (Mig-6), immediate early response gene encoding via threonine kinase receptors, plays an important role in maintaining joint homeostasis. Thus, the involvement of other cells may engage in the pathogenesis of OA [45].

In OA, a primary concern is the degeneration of articular cartilage [33]. The initial and repair stage of OA is characterized biochemically by an increased synthesis of ECM components, DNA, and metabolic activity of the chondrocytes. Accounting for the proliferation, mitoses, and clustering observed histologically [6,42,46]. The repair response is mediated by growth factors (e.g., insulin-like growth factor-1 (IGF-1) and transforming growth factor-β (TGF-β)), and is partially determined by the difussibility of these growth factor through the cartilage matrix to the chondrocytes [47-49]. Moreover, growth factors that are normally bound to the ECM components will be released by cartilage degradation and thereby stimulate the chondrocytes in their repair responses. Balance between repair and degradation established, an increased synthesis of the ECM components equals their degradation due to an increased protease activity [6].

To date, the molecular mechanism responsible for mediating the progression from defective subchondral bone to degeneration of articular cartilage in OA remains largely uncharacterized. Acknowledgment of the imbalance anabolic and inflammatory/ catabolic pathways has led to explored interest in treatment of OA with limited side effect that may be able to encourage maintenance of bone turnover and chondral homeostasis [39,44].

The TGF-β/Smad3 signaling system and OA

There are three subfamilies of TGF-β that closely related to the mammalian isoforms, TGF-β1, -β2, and -β3 [50,51]. Proteins of the TGF-β family mediate signaling pathways via serine/ threonine kinase receptors [52]. Specifically, type II serine/threonine kinase receptors (TGFβR II) are activated following their binding of type I serine/ threonine kinase receptors (TGFβR I) [53].

Intracellular Smad proteins (50-70 kDa), particularly Smad2 and Smad3, then transmit this activation signal and that of activin to the nucleus. In addition, when a Smad protein is activated by a receptor, its phosphorylated form is able to heterodimerize with Smad4 and translocate to the nucleus where the complex mediates the transactivation of specific target genes. Meanwhile, Smad1, Smad5, and Smad8 transduce signaling from BMP. Conversely, Smad6 and Smad7 provide an inhibitory function whereby phosphorylation of pathwayspecific Smads is inhibited and signal transduction is disrupted [53].

When chondrocyte-specific deletion of Smad3 was achieved in mice, OA in the knee joint was induced [54]. Correspondingly, in humans, mutations in Smad3 have been found in the MH2 domain of Smad3 protein, a region that is extremely well conserved among other species and among other Smad proteins that are associated with early onset of OA [55]. More recently, when overexpression of TGF-β1 was achieved in murine subchondral bone, mandibular condyle degradation was observed [56]. In our own study of mandibular condylar subchondral bone, spontaneous abnormalities were found to induce progressive cartilage degradation in Smad3−/− mice [57].

Chondrocyte death is commonly accepted as a hallmark of OA. It has been observed that the extent of chondrocyte death that occurs positively correlates with the severity of osteoarthritic cartilage depletion and destruction [58,59]. In our recent study, cell death in the condylar cartilage of Smad3−/− mice appeared to be progressive since the numbers of both TUNEL+ and active caspase-3+ and caspase-9+ cells did not significantly differ from those detected in 1-month-old Smad3−/− mice, yet they were markedly higher in the 4-month-old Smad3−/− mice [57].

S1P/S1PR system

In both healthy and disease states, the bioactive sphingolipid metabolite, sphingosine-1-phosphate (S1P), contributes to regulating many cellular processes [60]. For example, the ability of S1P to act via a family of cell surface receptors and to play a critical role in the migration of immune cells throughout the body has been well studied. In addition, control of cell trafficking is a well characterized aspect of the involvement of S1P in disease [61]. To date, there are five Gprotein- coupled receptors at the cell surface that have been found to be specific for S1P. They include S1PR1-5, and activation of S1P1 is critical for immune cell trafficking [62]. However, in the glomeruli of rats with diabetic nephropathy, it was recently observed that S1P signals are preferentially transmitted through S1P2, rather than S1P1 [63]. It is possible that this biased delivery of S1P signals may mediate the pathogenesis of endothelial injuries in diabetic nephropathy [63]. S1P2 was also recently shown to be expressed in enteric neurons and migrating cranial crest cells, while expression of S1P1 is significant in the neuroepithelium [64]. Meanwhile, S1P4 and S1P5 are expressed at later stages in neurons [64]. S1P3 primarily localizes to the cell surface on the plasma membrane, and high expression levels of S1P3 have been detected in lung, heart, kidney, spleen, diaphragm, and intestine tissues [65]. Moreover, for neurogenesis and for expression of smooth muscle alpha-actin following arterial injury [66], S1P3 has been found to be essential [67]. S1P3 also contributes to the migration of thyroid cancer cells [68] and VEGF-A secretion induced by S1P [69]. Furthermore, compared with other S1P receptor subtypes, S1P3 receptor antagonists have no effect on S1P-induced Mitogen-Activated Protein Kinase (MAPK) activation [70]. Thus, a role for S1P3 in MAPK signaling has been excluded.

Challenges for regenerative therapy approaches currently include modulation of MMPs, recruitment of chondroprogenitor cells to affected cartilage, and the impact of the extracellular matrix on cell migration [8-10]. Regarding the latter, the regulatory functions of bioactive lysophosholipids, primarily S1P, in cell migration have led to the identification of these proteins as potent mediators of wound healing and tissue repair. Moreover, S1P is released from most cells after they are stimulated by growth factors such as TGF-β. Therefore, S1P receptors should be considered in chondrocyte cell migration, despite a role of S1P receptors in OA being largely uncharacterized. Renal mesangial cells express several S1P receptors (e.g., S1P1-5), and these receptors potentially mediate mobilization of intracellular calcium, cell proliferation, and activation of the classic MAPK signaling cascade [71]. In the present study, wild type and Smad3−/− chondrocyte cells derived from condylar cartilage were analyzed [57]. The former expressed higher levels of S1P3 compared with the other S1P receptors assayed. Conversely, expression of S1P3 by the Smad3−/ − primary chondrocytes was significantly weaker. This difference in S1P3 expression was further enhanced following stimulation with TGF-β [57]. These results are consistent with the observation that signaling via the Sphk1/S1P3 axis is enhanced during the transdifferentiation of myoblasts into myofibroblasts in response to TGF [72,73]. However, it is important to note that knee hyaline articular cartilage is distinct from mandibular condylar cartilage.

S1P and TGF-β/Smad3 crosstalk in wound healing

It has been observed that TGF-β increases SphK1 activity and upregulates mRNA and protein levels of SphK1 in dermal fibroblasts [74]. Thus, it is hypothesized that crosstalk between TGF-β and S1P regulates MMP expression. S1P utilizes signaling by its receptors to stimulate phosphorylation and activation of TGFβR I kinase, thereby leading to phosphorylation of Smad2 and Smad3 independent of TGF- β ligand, as well as an induction of both proliferation and migration in keratinocytes [75]. Abrogation of Smad3 appears to prevent S1Pmediated effects [57,72,75,76], and this suggests a surprising, and yet essential, role for Smad3 in the signaling cascade of the lysophopholipid, S1P. A role for S1P3 in Smad3 activation was confirmed with the use of small interfering RNA (siRNA) targeting S1P3 and suramin [57,72]. Correspondingly, suramin was reported to be a selective agonist of the S1P3 receptor in vitro [77]. Abrogation of S1P-stimulated Smad3 activation by siRNA targeting TGFβR II further supports the hypothesis that TGFβR II is a component of the S1P signaling cascade [57].

For cell migration, Rho GTPases are critical for coordinating the cellular responses involved [78,79]. In the present study, the Rho GTPases that were assayed exhibited increased levels of activity following stimulation by TGF-β. However, when primary chondrocyte cells were transfected with siRNA targeting S1P3 and then were stimulated with TGF-β, the activity levels of GTP-Rac1, GTP-RhoA, and GTP-Cdc42 decreased [57].

Conclusion

Overall, these findings suggest a model in which chondrocyte cells are maintained via crosstalk between the TGF-β/Smad3 and S1P/S1P3 signaling pathways. The crosstalk between these pathways also regulates cell motility and apoptosis in these cells. Thus, Smad3/S1P3 signaling in chondrocytes may be responsible for the development of TMJ-OA, and the potential for these proteins to represent targets for the treatment of TMJ-OA warrants further study (Figure 1).

bone-marrow-research-chondrocyte-migration

Figure 1: A proposed model for the mechanisms by which crosstalk between the TGF-ß/Smad3 and S1P/S1P3 signaling pathways regulates chondrocyte migration. The maintenance of chondrocyte cells, which includes the processes of cell motility and apoptosis, is regulated by crosstalk between the TGF-ß/Smad3 and S1P/S1P3 signaling pathways. Furthermore, Smad3/S1P3 signaling in chondrocytes may play a crucial role in the cause of TMJ-OA.

Acknowledgments

This work was supported by the grants provided by JSPS KAKENHI (Grant Numbers. 25713063, 15K15757, 17K19758 to T.I. 16H07019 to H.M.), Otsuka Toshimi Scholarship Foundation (to I.H.), The Ichiro Kanehara Foundation, Suzuken Memorial Foundation, The Nakatomi Foundation, and Smoking Research Foundation (to T.I.).

Conflicts of Interest

The authors declare no conflict of interest.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 4th International Conference on Antimicrobials, Multiple Drug Resistance & Antibiotics Resistance April 20-21, 2018 Las Vegas, Nevada, USA
    April 20-21, 2018 Las Vegas, USA
  • Annual Physicians Meeting 2018 May 11-12, 2018 Osaka, Japan
    May 11-12, 2018 Osaka, Japan
  • International Conference on Internal Medicine May 21-22, 2018 Osaka, Japan
    May 21-22, 2018 Osaka, Japan
  • 7th International Conference on Clinical and Medical Case Reports June 01-02, 2018 Osaka, Japan
    June 01-02, 2018 Osaka, Japan
  • International conference on Fitness and Expo June 04-05, 2018 Baltimore, Maryland, USA
    June 4-5, 2018 Baltimore, USA
  • 3rd International Conference on Anesthesia June 21-22, 2018 Dublin, Ireland
    June 21-22, 2018 Dublin, Ireland
  • International Conference on Emergency & Acute Care Medicine August 22-23, 2018 Tokyo, Japan
    August 22-23, 2018 Tokyo, Japan
  • 14th International Conference on Clinical Gastroenterology and Hepatology August 29-30, 2018 Toronto, Ontario, Canada
    August 29-30, 2018 Toronto, Canada
  • World Conference on Neurology and Neuromuscular Disorders September 13-14, 2018 Frankfurt, Germany
    September 13-14, 2018 Frankfurt, Germany
  • 9th International Conference on Clinical & Medical Case Reports September 17-18, 2018 | Amsterdam, Netherlands
    September 17-18, 2018 Amsterdam, Netherlands
  • World Congress on Fetal and Maternal Medicine October 15-17, 2018 Osaka, Japan
    October 15-17, 2018 Osaka, Japan
  • Complementary & Alternative Medicine October 17-18, 2018 Las Vegas | Nevada | USA
    October 17-18, 2018 Las Vegas, USA
  • 11th International Conference on Clinical and Medical Case Reports October 22-23, 2018 Turkey
    October 22-23, 2018 Istanbul, Turkey

Article Usage

  • Total views: 408
  • [From(publication date):
    September-2017 - Apr 21, 2018]
  • Breakdown by view type
  • HTML page views : 367
  • PDF downloads : 41
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]csonline.com

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version